Cleo Diagnostics (ASX:COV) Common Stock: A$18.09 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:COV Cleo Diagnostics Ltd ASX:COV
14 GF Score
Price A$0.45
! 1 Warning Sign
View Full Analysis

What is Cleo Diagnostics Common Stock?

Cleo Diagnostics ASX:COV -7.22% 14 Common Stock is A$18.09 Mil as of Dec. 2025. GuruFocus rates ASX:COV with a GF Score™ of 14/100. The stock has 1 warning sign investors should review.

Cleo Diagnostics's quarterly common stock stayed the same from Dec. 2024 (A$13.71 Mil) to Jun. 2025 (A$13.71 Mil) but then increased from Jun. 2025 (A$13.71 Mil) to Dec. 2025 (A$18.09 Mil).

Cleo Diagnostics's annual common stock increased from Jun. 2023 (A$0.05 Mil) to Jun. 2024 (A$13.71 Mil) but then stayed the same from Jun. 2024 (A$13.71 Mil) to Jun. 2025 (A$13.71 Mil).

Cleo Diagnostics Common Stock Historical Data

* Premium members only.

The historical data trend for Cleo Diagnostics's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cleo Diagnostics Common Stock Chart

Cleo Diagnostics Annual Data
Trend Jun23 Jun24 Jun25
Common Stock
0.05 13.71 13.71

Cleo Diagnostics Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial 13.71 13.71 13.71 13.71 18.09
ASX:COV
14GF Score
Cleo Diagnostics Ltd ASX:COV
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cleo Diagnostics Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of A$18.09 Mil mean?
Cleo Diagnostics (ASX:COV) has a Common Stock of A$18.09 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Cleo Diagnostics and its competitors.
Is Cleo Diagnostics' Common Stock too high?
Cleo Diagnostics' current Common Stock is A$18.09 Mil. Overall, Cleo Diagnostics has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Cleo Diagnostics' Common Stock compare to ABT and SYK?
Cleo Diagnostics' Common Stock of A$18.09 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Devices & Instruments company?
A good Common Stock depends on the Medical Devices & Instruments industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Cleo Diagnostics and its competitors. Cleo Diagnostics's current Common Stock is A$18.09 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cleo Diagnostics stock overvalued right now?
Cleo Diagnostics (ASX:COV) has a current Common Stock of A$18.09 Mil. The current Common Stock is A$18.09 Mil. Cleo Diagnostics' overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Cleo Diagnostics (ASX:COV), the current Common Stock is A$18.09 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cleo Diagnostics Business Description

Address 480 Collins Street, Level 2, Melbourne, VIC, AUS, 3000
Cleo Diagnostics Ltd is focused on the development of non-invasive blood-based IVD tests to detect the presence, and recurrence, of ovarian cancer. The company's first product to market is intended to be the Triage Test which results to accurately differentiate patients with malignant ovarian cancer from those with benign gynecological conditions. The company aims to improve the diagnostic process and procedures for detecting ovarian cancer and, in this regard, improve quality-of-life outcomes for patients who have been diagnosed with ovarian cancer.
14GF Score

Get the complete analysis for ASX:COV

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.45
Price